首页> 外国专利> COMPOSITION OF PACLITAXEL INJECTION HAVING IMPROVED CELL MEMBRANE PERMEABILITY AND EXCELLENT ANTICANCER EFFICACY

COMPOSITION OF PACLITAXEL INJECTION HAVING IMPROVED CELL MEMBRANE PERMEABILITY AND EXCELLENT ANTICANCER EFFICACY

机译:改善细胞膜通透性和优异抗癌功效的帕金沙星注射液的组成

摘要

PURPOSE: Provided is a composition of paclitaxel injection which has high solubility of drugs and extended storage as well as improved cell membrane permeability and excellent anticancer efficacy. CONSTITUTION: The composition of paclitaxel injection having improved cell membrane permeability is characterized by comprising 0.0001-10 wt.% of paclitaxel, 30-49.999 wt.% of solubilizing agent selected from (oxyethylene)l sorbitol (olate)m or (oxyethylene)l sorbitan (olate)m, wherein l is an integer of 15-60 and m is an integer of 1-4, 0.0001-30 wt.% of cell membrane permeability-improving agent selected from conjugated linoleic acid phosphatidyl choline and docosahexaenoic acid phosphatidyl choline, and 30-49.999 wt.% of anhydrous alcohol selected from anhydrous ethanol, anhydrous isopropylalcohol, anhydrous-n-propylalcohol and t-butylalcohol.
机译:目的:提供一种紫杉醇注射液的组合物,其具有较高的药物溶解度和延长的储存时间,并改善了细胞膜的通透性和优异的抗癌功效。组成:紫杉醇注射液具有改善的细胞膜通透性的组合物,其特征在于包含0.0001-10重量%的紫杉醇,30-49.999重量%的选自(氧乙烯)l山梨醇(油酸酯)m或(氧乙烯)l的增溶剂。脱水山梨糖醇(油酸酯)m,其中l是15-60的整数,m是1-4的整数,选自共轭亚油酸磷脂酰胆碱和二十二碳六烯酸磷脂酰胆碱的0.0001-30 wt。%的细胞膜通透性改善剂;和30-49.999 wt。%的选自无水乙醇,无水异丙醇,无水正丙基醇和叔丁基醇的无水醇。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号